These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28236987)

  • 1. [What place for placebo in clinical trials conducted on psychiatric patients?].
    Cermolacce M; Belzeaux R; Adida M; Micoulaud Franchi JA; Fakra E; Azorin JM
    Encephale; 2016 Dec; 42(6S):S18-S25. PubMed ID: 28236987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of clinical trials of antidepressants.
    Quitkin FM; Rabkin JG; Gerald J; Davis JM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):327-37. PubMed ID: 10698806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increasing power of placebos in trials of antidepressants.
    Schneider LS; Small GW
    JAMA; 2002 Jul 24-31; 288(4):450. PubMed ID: 12132971
    [No Abstract]   [Full Text] [Related]  

  • 10. The increasing power of placebos in trials of antidepressants.
    Sapir M
    JAMA; 2002 Jul 24-31; 288(4):450. PubMed ID: 12132970
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
    Tedeschini E; Fava M; Papakostas GI
    J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebos, drug effects, and study design: a clinician's guide.
    Quitkin FM
    Am J Psychiatry; 1999 Jun; 156(6):829-36. PubMed ID: 10360119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining efficacy in controlled trials of antidepressants: effects of placebo dropout.
    Schalkwijk S; Undurraga J; Tondo L; Baldessarini RJ
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1343-52. PubMed ID: 24621827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do the terms "drug-specific response/remission rate" and "placebo" really mean?
    Preskorn SH
    J Psychiatr Pract; 2011 Nov; 17(6):420-4. PubMed ID: 22108399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What conditions are necessary to assess antidepressant efficacy?
    Quitkin FM; Klein DF
    Arch Gen Psychiatry; 2000 Apr; 57(4):323-4. PubMed ID: 10768690
    [No Abstract]   [Full Text] [Related]  

  • 19. Are antidepressants overrated? A review of methodological problems in antidepressant trials.
    Moncrieff J
    J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increasing power of placebos in trials of antidepressants.
    Brandon TH; Irvin JE; Hendricks PS
    JAMA; 2002 Jul 24-31; 288(4):449-50. PubMed ID: 12132969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.